# A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic Population

> **NCT02420028** · NA · TERMINATED · sponsor: **Optomeditech Oy** · enrollment: 109 (actual)

## Conditions studied

- Intravenous Injections

## Interventions

- **DEVICE:** Insertion of OptiVein IV catheter
- **DEVICE:** Insertion of Vasofix Certo IV catheter

## Key facts

- **NCT ID:** NCT02420028
- **Lead sponsor:** Optomeditech Oy
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04-02
- **Primary completion:** 2016-08-05
- **Final completion:** 2016-08-05
- **Target enrollment:** 109 (ACTUAL)
- **Why stopped:** Inability to recruit patients sufficiently
- **Last updated:** 2018-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02420028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02420028, "A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic Population". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02420028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*